This fund aims to achieve long-term capital growth for its investors. It primarily allocates its capital to equity securities. A substantial portion, at least 80%, of the portfolio is dedicated to firms whose core business revolves around the design, manufacturing, or sale of products and services within the healthcare and medical fields. The fund invests in companies operating both domestically and internationally. Its investment choices are guided by a thorough fundamental analysis, scrutinizing factors such as each company's financial stability, its competitive position in the industry, and the broader economic and market environment.